Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Canfrán-Duque

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Opinion in Pharmacology|July 25, 2012
Post-lanosterol biosynthesis of cholesterol and cancerMiguel A Lasunción, Covadonga Martín-Sánchez, Alberto Canfrán-Duque, et al.
Journal of Cell Science|July 12, 2015
The miR-199-dynamin regulatory axis controls receptor-mediated endocytosisJuan F Aranda, Alberto Canfrán-Duque, Leigh Goedeke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2016
Micro-RNAs and High-Density Lipoprotein MetabolismAlberto Canfrán-Duque, Chin-Sheng Lin, Leigh Goedeke, et al.
Cardiovascular Research|June 5, 2014
microRNAs and HDL life cycleAlberto Canfrán-Duque, Cristina M Ramírez, Leigh Goedeke, et al.
Circulation Research|February 2, 2019
Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque DevelopmentNathan L Price, Noemi Rotllan, Xinbo Zhang, et al.
Plos One|October 31, 2015
Curcumin Mitigates the Intracellular Lipid Deposit Induced by Antipsychotics In VitroAlberto Canfrán-Duque, Oscar Pastor, Manuel Reina, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Antagonism of miR-148a attenuates atherosclerosis progression in APOB<sup>TG</sup>Apobec<sup>-/-</sup>Ldlr<sup>+/-</sup> mice: A brief reportNoemi Rotllan, Xinbo Zhang, Alberto Canfrán-Duque, et al.
Science Signaling|November 5, 2015
Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptakeJonathan W Haskins, Shannon Zhang, Robert E Means, et al.
International Journal of Molecular Sciences|March 22, 2016
First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in VitroAlberto Canfrán-Duque, Luis C Barrio, Milagros Lerma, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2026
AUF1 therapy blocks atrophy, promotes regeneration, re-innervation and strength for severe muscle injuryDounia Abbadi, Olga Katsara, Riley McConnell, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Opinion in Pharmacology|July 25, 2012
Post-lanosterol biosynthesis of cholesterol and cancerMiguel A Lasunción, Covadonga Martín-Sánchez, Alberto Canfrán-Duque, et al.
Journal of Cell Science|July 12, 2015
The miR-199-dynamin regulatory axis controls receptor-mediated endocytosisJuan F Aranda, Alberto Canfrán-Duque, Leigh Goedeke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2016
Micro-RNAs and High-Density Lipoprotein MetabolismAlberto Canfrán-Duque, Chin-Sheng Lin, Leigh Goedeke, et al.
Cardiovascular Research|June 5, 2014
microRNAs and HDL life cycleAlberto Canfrán-Duque, Cristina M Ramírez, Leigh Goedeke, et al.
Circulation Research|February 2, 2019
Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque DevelopmentNathan L Price, Noemi Rotllan, Xinbo Zhang, et al.
Plos One|October 31, 2015
Curcumin Mitigates the Intracellular Lipid Deposit Induced by Antipsychotics In VitroAlberto Canfrán-Duque, Oscar Pastor, Manuel Reina, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Antagonism of miR-148a attenuates atherosclerosis progression in APOB<sup>TG</sup>Apobec<sup>-/-</sup>Ldlr<sup>+/-</sup> mice: A brief reportNoemi Rotllan, Xinbo Zhang, Alberto Canfrán-Duque, et al.
Science Signaling|November 5, 2015
Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptakeJonathan W Haskins, Shannon Zhang, Robert E Means, et al.
International Journal of Molecular Sciences|March 22, 2016
First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in VitroAlberto Canfrán-Duque, Luis C Barrio, Milagros Lerma, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2026
AUF1 therapy blocks atrophy, promotes regeneration, re-innervation and strength for severe muscle injuryDounia Abbadi, Olga Katsara, Riley McConnell, et al.
Pageof 4